Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Peptides for Testosterone Boost: Mechanism Comparison

| Peptide | Target Receptor | Mechanism | Half-Life | Typical Dosing | Primary Use Case | Professional Assessment ||—|—|—|—|—|—|| Kisspeptin-10 | GPR54 (hypothalamus) | Stimulates pulsatile GnRH release | 28 minutes | 0.24 nmol/kg SC daily | Functional hypogon

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • | Peptide | Target Receptor | Mechanism | Half-Life | Typical Dosing | Primary Use Case | Professional Assessment ||—|—|—|—|—|—|| Kisspeptin-10 | GPR54 (hypothalamus) | Stimulates pulsatile GnRH release | 28 minutes | 0.24 nmol/kg SC daily | Functional hypogonadism, blunted GnRH tone | Most physiologic. Preserves entire HPG axis but requires frequent dosing || Gonadorelin | GnRH receptors (pituitary) | Direct GnRH agonist, stimulates LH/FSH | 2–10 minutes | 25–100 mcg pulsatile every 90–120 min | Hypogonadotropic hypogonadism, impaired hypothalamic signaling | Effective but logistically complex. Requires infusion pump for pulsatile delivery || hCG | LH/hCG receptors (Leydig cells) | LH analogue, directly stimulates testosterone synthesis | 24–36 hours | 250–500 IU SC twice weekly | TRT preservation, primary hypogonadism, anabolic steroid PCT | Most practical for sustained testosterone support. Bypasses upstream failures || Clomiphene (SERM) | Estrogen receptors (hypothalamus/pituitary)